Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
What New State Health Care Proposals Could Mean for Workers' Comp and Auto
Single-payer proposals may not be changing workers’ compensation or auto medical benefits just yet, but they signal a policy direction that could a
Workers' Comp
Article
Catastrophic Claims Need a Lifetime Roadmap
Catastrophic exposure creates a different kind of pressure. You are not just paying for treatment. You are managing a lifetime problem.
Workers' Comp
Article
Building Resilience Through Crisis Intervention
Critical incidents are unusually challenging events that overwhelm usual coping.
Workers' Comp
Article
Ask The Pharmacist: What Work Comp Adjusters Should Know About New Generic Tapentadol
Is generic Nucynta IR and ER a new option for treating injured employees? Generic versions of Nucynta are now available in the U.S.
Workers' Comp
Article
How High-Performing Networks Deliver More Value
P&C leaders are feeling the mounting pressure to control overall claim spend in the face of rising medical costs, while maintaining access to c
Business Insurance
In the News